Literature DB >> 8676085

The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice.

M B Baker1, N H Altman, E R Podack, R B Levy.   

Abstract

The role of cell-mediated cytotoxicity in the complex pathophysiology of graft-versus-host disease (GVHD) has remained poorly defined for several decades. We transplanted T cells from Fas-ligand (FasL)-defective and perforin-deficient mutant donor mice into lethally irradiated MHC-matched allogeneic recipient mice to characterize the role of cell-mediated cytotoxicity in GVHD. Although recipients of allogeneic FasL-defective donor T cells underwent severe GVHD-associated cachexia, they exhibited only minimal signs of hepatic and cutaneous GVHD pathology. Recipients of perforin-deficient allogeneic donor T cells developed signs of acute GVHD, but the time of onset was significantly delayed. These findings demonstrate that Fas-mediated anti-recipient cytotoxicity may be critical for the development of hepatic and cutaneous GVHD, but is not required for GVHD-associated cachexia. In addition, perforin-mediated anti-recipient cytotoxicity appears to play an important role in the kinetics of GVHD pathophysiology, but is not required for GVHD-associated tissue damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676085      PMCID: PMC2192602          DOI: 10.1084/jem.183.6.2645

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  Correlation of graft-versus-host mortality and positive CML assay in the mouse.

Authors:  W L Elkins
Journal:  Transplant Proc       Date:  1976-09       Impact factor: 1.066

2.  Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.

Authors:  B Lowin; M Hahne; C Mattmann; J Tschopp
Journal:  Nature       Date:  1994-08-25       Impact factor: 49.962

3.  Abrogation of graft-versus-host disease following allotransplantation of cytotoxically deficient bone marrow across major histocompatibility barriers.

Authors:  G Selvaggi; L Inverardi; R B Levy; M D Brendel; J Spielman; D H Mintz; E R Podack; C Ricordi
Journal:  Ann N Y Acad Sci       Date:  1995-12-29       Impact factor: 5.691

4.  Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors.

Authors:  K G Lerner; G F Kao; R Storb; C D Buckner; R A Clift; E D Thomas
Journal:  Transplant Proc       Date:  1974-12       Impact factor: 1.066

5.  The ultrastructure of the human epidermis in chronic graft-versus-host disease.

Authors:  B B Gallucci; H M Shulman; G E Sale; K G Lerner; L E Caldwell; E D Thomas
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

6.  Pathology of the liver with bone marrow transplantation. Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection.

Authors:  W E Beschorner; J Pino; J K Boitnott; P J Tutschka; G W Santos
Journal:  Am J Pathol       Date:  1980-05       Impact factor: 4.307

7.  Expression of the Fas ligand in cells of T cell lineage.

Authors:  T Suda; T Okazaki; Y Naito; T Yokota; N Arai; S Ozaki; K Nakao; S Nagata
Journal:  J Immunol       Date:  1995-04-15       Impact factor: 5.422

8.  Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia.

Authors:  H G Prentice; H A Blacklock; G Janossy; K F Bradstock; D Skeggs; G Goldstein; A V Hoffbrand
Journal:  Lancet       Date:  1982-03-27       Impact factor: 79.321

9.  Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.

Authors:  S Miyashima; N Nagata; T Nakagawa; N Hosaka; K Takeuchi; R Ogawa; S Ikehara
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

10.  Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.

Authors:  R Korngold; J Sprent
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  66 in total

1.  Prostaglandins and the induction of food sensitive enteropathy.

Authors:  A M Mowat
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

2.  Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes.

Authors:  Keli L Hippen; Christoph Bucher; Dawn K Schirm; Amanda M Bearl; Ty Brender; Kathy A Mink; Kimberly S Waggie; Regis Peffault de Latour; Anne Janin; Julie M Curtsinger; Stacey R Dillon; Jeffrey S Miller; Gerard Socie; Bruce R Blazar
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

3.  Graft-versus-host-disease-associated donor cell engraftment in an F1 hybrid model is dependent upon the Fas pathway.

Authors:  T Iwasaki; T Hamano; K Saheki; T Kuroiwa; Y Kataoka; Y Takemoto; A Ogata; J Fujimoto; E Kakishita
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

4.  Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation.

Authors:  T A Graubert; J F DiPersio; J H Russell; T J Ley
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 5.  Keratinocyte apoptosis in epidermal development and disease.

Authors:  Deepak Raj; Douglas E Brash; Douglas Grossman
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

6.  Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity.

Authors:  A Shustov; I Luzina; P Nguyen; J C Papadimitriou; B Handwerger; K B Elkon; C S Via
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 7.  Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.

Authors:  Arnab Ghosh; Amanda M Holland; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease.

Authors:  Y Onoe; M Harada; K Tamada; K Abe; T Li; H Tada; K Nomoto
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

9.  Fas/Fas ligand mediates keratinocyte death in sunitinib-induced hand-foot skin reaction.

Authors:  Chun-Nan Yeh; Wen-Hung Chung; Shih-Chi Su; Yen-Yang Chen; Chi-Tung Cheng; Yen-Ling Lin; Wan-Chun Chang; Rosaline Chung-Yee Hui; Kun-Chun Chiang; Tsung-Wen Chen; Yi-Yin Jan; Chien-Wei Chen; Ting-Jui Chen; Chih-Hsun Yang; Shuen-Iu Hung
Journal:  J Invest Dermatol       Date:  2014-05-06       Impact factor: 8.551

10.  A novel role for the semaphorin Sema4D in the induction of allo-responses.

Authors:  Raimon Duran-Struuck; Isao Tawara; Kathi Lowler; Shawn G Clouthier; Elizabeth Weisiger; Clare Rogers; Gary Luker; Atsushi Kumanogoh; Chen Liu; James L M Ferrara; Pavan Reddy
Journal:  Biol Blood Marrow Transplant       Date:  2007-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.